Faculty

Andy Stergachis

Adjunct Professor, Epidemiology
Professor, Pharmacy
Professor, Global Health
Adjunct Professor, Health Metrics Sciences
Adjunct Professor, Health Services
Associate Dean, School of Pharmacy

206-221-0703
stergach@uw.edu

Education

PhD Pharmacy, University of Minnesota, 1979
MS Pharmacy, University of Minnesota, 1976
BPharm Pharmacy, Washington State University, 1975

Contact

206-221-0703
stergach@uw.edu

Office H-362B, Health Sciences Building
Box 357631
WA

Research Interests

Dr. Stergachis' research focus is pharmacoepidemiology, global drugs and vaccine safety, pharmaceutical outcomes research, and public health systems research. He directed a pharmacovigilance pregnancy registry study on the safety of first trimester antimalarials conducted in three sub-Saharan African countries. He is one of very few pharmacists ever elected to the National Academy of Medicine. His research has been supported, in part, by the Bill and Melinda Gates Foundation, USAID, the Barr Foundation, the Partnership for Quality Medical Donations, and USP. He is a Fellow of the International Society for Pharmacoepidemiology, Chair of the Expert Panel to Review Surveillance and Screening Technologies for the Quality Assurance of Medicines for United States Pharmacopeia, Chair of the Low-dose Primaquine Safety Study Group for the WorldWide Antimalarial Resistance Network and member of the Access and Product Management Advisory Committee for Medicines for Malaria Venture. He has conducted pharmacovigilance trainings and related pharmaceutical systems strengthening activities in numerous low- and middle-income countries (e.g., Namibia, Vietnam, Rwanda, Ethiopia, Zimbabwe, China, India, Kenya, Bangladesh, Eritrea, Philippines, Uganda, and Ukraine). Through his affiliation with the Northwest Center for Public Health Practice, he also works on workforce development and research in emergency preparedness with the public health community.

Recent Publications (PubMed)

Maternal and neonatal data collection systems in low- and middle-income countries for maternal vaccines active safety surveillance systems: A scoping review.
(2021 Mar 17)
BMC Pregnancy Childbirth 21(1): 217
Berrueta M, Ciapponi A, Bardach A, Cairoli FR, Castellano FJ, Xiong X, Stergachis A, Zaraa S, Meulen AS, Buekens P, Scoping Review Collaboration Group.

Community pharmacists' role in caring for people living with epilepsy: A scoping review.
(2021 Apr)
Epilepsy Behav 117(): 107850
Bacci JL, Zaraa S, Stergachis A, Simic G, White HS

Strengthening pandemic preparedness through pharmacy and public health collaborations: Findings from a facilitated discussion exercise.
(2021 Jan 18)
J Am Pharm Assoc (2003)
Bacci JL, Odegard P, Arnold J, Stergachis A

Antimicrobial use across six referral hospitals in Tanzania: a point prevalence survey.
(2020 Dec 15)
BMJ Open 10(12): e042819
Seni J, Mapunjo SG, Wittenauer R, Valimba R, Stergachis A, Werth BJ, Saitoti S, Mhadu NH, Lusaya E, Konduri N

National Consumption of Antimicrobials in Tanzania: 2017-2019.
(2020)
Front Pharmacol 11(): 585553
Mbwasi R, Mapunjo S, Wittenauer R, Valimba R, Msovela K, Werth BJ, Khea AM, Nkiligi EA, Lusaya E, Stergachis A, Konduri N

Show complete publication list